Found 80 Enz. Inhib. hit(s) with all data for entry = 50010394 TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 36nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 37nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 47nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 48nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 58nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 68nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 72nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 97nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 102nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 105nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 121nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 128nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 138nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 140nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 143nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 155nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 160nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 161nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 175nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 179nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 179nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 211nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 220nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 232nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 238nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 238nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 242nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 259nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 275nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 287nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 289nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 298nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 325nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 326nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 342nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 359nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 365nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 368nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 391nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 391nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 392nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 412nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 441nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 447nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 1(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 459nMAssay Description:Inhibition of GLUT1 in human wild-type DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
TargetSolute carrier family 2, facilitated glucose transporter member 3(Homo sapiens (Human))
Kadmon
Curated by ChEMBL
Kadmon
Curated by ChEMBL
Affinity DataIC50: 482nMAssay Description:Inhibition of GLUT3 in SLC2A1-deficient human DLD1 cells assessed as reduction in ATP level measured after 90 mins by Celltiter-glo luminescent assayMore data for this Ligand-Target Pair
